Nyumbani › Burkitt Lymphoma › Illinois
Majaribio ya kliniki ya Burkitt Lymphoma katika jimbo la Illinois
Masomo 14 ya Burkitt Lymphoma yanatafuta washiriki katika vituo vya jimbo la Illinois.
Miji katika jimbo la Illinois
Maandishi rasmi ya utafiti (Kiingereza)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- na zaidi ya 4
InaajiriHatua 2
366 Days – 46 Years · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06124157Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
- University of Illinois, Chicago
- na zaidi ya 7
InaajiriHatua 3
Umri 18 hadi 39 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT03150693Blinatumomab Consolidation in Real World
- Northwestern University, Chicago
- The University of Chicago, Chicago
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT07117136Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- Northwestern University, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- na zaidi ya 9
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT03739814Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Lurie Children's Hospital-Chicago, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- Advocate Children's Hospital-Oak Lawn, Oak Lawn
- na zaidi ya 3
InaajiriHatua 2
365 Days · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06317662A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- na zaidi ya 2
InaajiriHatua 2
Umri 1 hadi 30 · Jinsia zote · Imesasishwa 1 Sep 2026 · NCT04546399Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- na zaidi ya 5
InaajiriHatua 3
365 Days – 25 Years · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT03959085Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
InaajiriHatua 2
Umri 7 hadi 25 · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT05082519AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Research Site, Chicago
InaajiriHatua 1/2
Umri 12 na zaidi · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT06137118Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Research Site, Chicago
InaajiriHatua 1/2
Umri 12 na zaidi · Jinsia zote · Imesasishwa 13 Jul 2026 · NCT07109219Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- University of Chicago Comprehensive Cancer Center, Chicago
InaajiriHatua 2
Umri 18 hadi 54 · Jinsia zote · Imesasishwa 17 Mac 2026 · NCT06918431ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
- University of Chicago Comprehensive Cancer Center, Chicago
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Nov 2025 · NCT03595917Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
- University of Chicago, Chicago
InaajiriHatua 1/2
Umri 15 hadi 50 · Jinsia zote · Imesasishwa 9 Sep 2025 · NCT04150497Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Inaajiri
Umri 18 hadi 50 · Jinsia zote · Imesasishwa 19 Jun 2025 · NCT06785324Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.